Form D — AdvanCell, Inc.

0000950172-26-000185 · filed Jul 16, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $315,000,000
Reported amount sold: $218,333,294
Minimum investment: $0
Investors: 41
Sales commission: $0
Finders' fees: $0

Issuer

Name: AdvanCell, Inc.
CIK: 2144758
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2026
Address: 245 MAIN STREET
CAMBRIDGE, MA 02142
Phone: +64 22 799 1300

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Andrew Kay · Director

Cambridge, MA Find on LinkedIn ↗
Kevin Cameron · Director

Cambridge, MA Find on LinkedIn ↗
Philina Lee · Executive Officer

Cambridge, MA Find on LinkedIn ↗
Aaron Pickett · Executive Officer

Cambridge, MA Find on LinkedIn ↗
Wing Cheong Lam · Director

Cambridge, MA Find on LinkedIn ↗
Nik Economopoulos · Director

Cambridge, MA Find on LinkedIn ↗
Anthony Aiudi · Director

Cambridge, MA Find on LinkedIn ↗
Bali Muralidhar · Director

Cambridge, MA Find on LinkedIn ↗
Jamil Beg · Director

Cambridge, MA Find on LinkedIn ↗
Christopher Gagliardi · Director

Cambridge, MA Find on LinkedIn ↗
Andrew Adamovich · Director

Cambridge, MA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗